These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6475933)

  • 1. An analysis of the mechanism by which cetiedil inhibits the Gardos phenomenon.
    Berkowitz LR; Orringer EP
    Am J Hematol; 1984 Oct; 17(3):217-23. PubMed ID: 6475933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cetiedil on cation and water movements in erythrocytes.
    Schmidt WF; Asakura T; Schwartz E
    J Clin Invest; 1982 Mar; 69(3):589-94. PubMed ID: 7061704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A further characterization of the selective K movements observed in human red blood cells following acetylphenylhydrazine exposure.
    Orringer EP
    Am J Hematol; 1984 May; 16(4):355-66. PubMed ID: 6720681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability.
    Berkowitz LR; Orringer EP
    J Clin Invest; 1981 Nov; 68(5):1215-20. PubMed ID: 7298848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cetiedil on red cell membrane permeability.
    Schmidt WF; Asakura T; Schwartz E
    Blood Cells; 1982; 8(2):289-98. PubMed ID: 7159753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of erythrocyte calcium transport by cetiedil.
    Levine SN; Berkowitz LR; Orringer EP
    Pharmacology; 1988; 36(1):44-51. PubMed ID: 2829242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
    Berkowitz LR; Orringer EP
    Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells.
    Benton DC; Roxburgh CJ; Ganellin CR; Shiner MA; Jenkinson DH
    Br J Pharmacol; 1999 Jan; 126(1):169-78. PubMed ID: 10051133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of the mechanism by which cetiedil inhibits sickling.
    Abu-Salah KM; Gambo AH
    Life Sci; 2002 Jan; 70(9):1003-11. PubMed ID: 11860149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cetiedil on the superoxide-generating system of porcine neutrophils.
    Chiba T; Asakura T; Kakinuma K
    J Biochem; 1985 Aug; 98(2):355-61. PubMed ID: 2999093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of blocking agents applied to the inner face of Ca(2+)-activated K+ channels from human erythrocytes.
    Dunn PM
    J Membr Biol; 1998 Sep; 165(2):133-43. PubMed ID: 9745001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca(2+)-activated K+ permeability of erythrocytes.
    Roxburgh CJ; Ganellin CR; Athmani S; Bisi A; Quaglia W; Benton DC; Shiner MA; Malik-Hall M; Haylett DG; Jenkinson DH
    J Med Chem; 2001 Sep; 44(20):3244-53. PubMed ID: 11563923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action and comparative efficacy of pharmacological agents that inhibit calcium-dependent dehydration of sickle cells.
    Ellory JC; Nash GB; Stone PC; Culliford SJ; Horwitz E; Stuart J
    Br J Pharmacol; 1992 Aug; 106(4):972-7. PubMed ID: 1393295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bepridil and cetiedil reversibly inhibit thyroid hormone stimulation in vitro of human red cell Ca2+-ATPase activity.
    Dube MP; Davis FB; Davis PJ; Blas SD
    Mol Endocrinol; 1987 Feb; 1(2):168-71. PubMed ID: 2970587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic activity of cetiedil and its analogues.
    Haring J; Mesangeau D; Huet Y; Aurousseau M
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):467-81. PubMed ID: 6110633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of conductive anion permeability in cultured cells by cetiedil.
    Breuer WV; Mack E; Rothstein A
    Biochim Biophys Acta; 1987 Feb; 897(1):127-34. PubMed ID: 2432937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloride permeability in human red cells: influence of membrane protein rearrangement resulting from ATP depletion and calcium accumulation.
    Motais R; Baroin A; Baldy S
    J Membr Biol; 1981; 62(3):195-206. PubMed ID: 6799647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
    Agre P; Virshup D; Bennett V
    J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-induced membrane depolarization of platelets and its inhibition by cetiedil.
    Yamaguchi A; Azuma H; Sekizaki S; Suzuki H; Tanoue K; Yamazaki H
    J Biochem; 1988 May; 103(5):787-91. PubMed ID: 3182748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.